Clinical Trial - Trial ChiCTR2200060566
Access comprehensive clinical trial information for ChiCTR2200060566 through Pure Global AI's free database. This Phase 2 trial is sponsored by Qilu Hospital of Shandong University and is currently Not yet recruiting. The study focuses on Prostate cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200060566
Phase 2
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2200060566
View on Chinese Clinical Trial Registry
Untitled Trial
An exploratory clinical study of fluzoparib combined with abiraterone in preoperative neoadjuvant treatment of high-risk localized prostate cancer and oligometastatic prostate cancer
Study Focus
Sponsor & Location
Qilu Hospital of Shandong University
own
China
Timeline & Enrollment
Phase 2
N/A
May 30, 2024
ICD-10 Classifications
Malignant neoplasm of prostate
Hyperplasia of prostate
Disorder of prostate, unspecified
Other disorders of prostate
Carcinoma in situ: Prostate
Data Source
Chinese Clinical Trial Registry
ChiCTR2200060566
Non-Device Trial